comparemela.com

Latest Breaking News On - வன்பொன் வப்பே - Page 4 : comparemela.com

Could Michigan Be the Perfect Entry Point for Cannabis Investors

Could Michigan Be the Perfect Entry Point for Cannabis Investors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC (MMEDF), Red White & Bloom Brands (RWBYF) - Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Once Dismissed as a Fringe, Counterculture Vice, Psychedelics Are Rapidly Approaching Acceptance in Mainstream Medicine These drugs uniquely change the brain, and a person’s awareness of experiences, in the span of just a few hours. This fast-acting shift could be useful in mental-health treatments, and research is already supporting this notion. Just one dose of Psilocybin, the active ingredient in Magic Mushrooms, was recently shown to ease depression and anxiety in cancer patients an outcome that lasted for years after their trip. Researchers are recognizing that Psychedelics can provide a radical new approach to mental-health treatments at a time when innovation is desperately needed. Ibogaine is one of the most promising psychedelics for addiction. Now, for the first time, some upstart pharmaceutical companies, including ATAI Life Sciences and 

COMP SERVICES (CMPS), CURALEAF HLDGS INC by Curaleaf Hldgs Inc (CURLF), FIELD TRIP HEALTH LTD by Field Trip Health Ltd (FTRPF), JUSHI HLDGS INC CL B by Jushi Holdings Inc (JUSHF), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC (MMEDF), Red White & Bloom Brands (RWBYF) - Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

COMP SERVICES (CMPS), CURALEAF HLDGS INC by Curaleaf Hldgs Inc (CURLF), FIELD TRIP HEALTH LTD by Field Trip Health Ltd (FTRPF), JUSHI HLDGS INC CL B by Jushi Holdings Inc (JUSHF), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC (MMEDF), Red White & Bloom Brands (RWBYF) - Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

A Growing Number of Product Categories Lifts the CBD Marketplace

A Growing Number of Product Categories Lifts the CBD Marketplace FinancialBuzz.com News Commentary Share this article Share this article NEW YORK, April 5, 2021 /PRNewswire/ Presently, the medical cannabis sector accounts for a majority of the market share, as progress is slowly being made in removing the stigmas associated with such products. Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry. While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward. For example, last week, New York became the latest state to legalize recreational cannabis, and in doing so is expected to become one of the nation s largest markets. New York s new law to tax and regulate cannabis includes various major provisions designed to create a diverse business mix of large and small operators, and it will

COMP SERVICES (CMPS), FIELD TRIP HEALTH LTD by Field Trip Health Ltd (FTRPF), Greenstar Biosciences (GTSIF), Johnson & Johnson (JNJ), NUMINUS WELLNESS INC by NUMINUS WELLNESS INC (LKYSD), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC (MMEDF), MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC (MYCOF), Red White & Bloom Brands (RWBYF) - Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Significant Progress Made as Numinus-Sponsored PRIME Study on Psilocybin-Assisted Psychotherapy for Opioid, Stimulant and/or Alcohol Use Disorders Enters Pre-Implementation Stage Numinus Wellness (OTC:LKYSD) and  Syreon Corporation, a global contract research organization with expertise in conducting clinical trials across a broad range of diseases, are pleased to share that significant progress has been made in the single-arm, open-label compassionate access1 trial of Psilocybin-Research Intervention with Motivational Enhancement (PRIME) for substance use disorders. The study will contribute to a growing body of research to inform larger randomized controlled trials for these indications. The study will take place in Vancouver and will enroll 30 individuals with opioid, stimulant and/or alcohol use disorders. Syreon is leading the trial as Clinical Research Organization (CRO) with Numinus as the trial sponsor.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.